Skip to content

 

For Medical Professionals

Video placeholder

CAR T-cell Therapy: For Physicians

Medical oncologist Michael Bishop, MD, director of UChicago Medicine's adult cellular therapy program, answers questions about CAR T-cell therapy, when to refer a patient, and more.

Play video

Refer an Adult Patient

Yescarta (axicabtagene ciloleucel) CAR T-cell therapy is available for patients with: 

  • Large B-cell lymphoma after at least two other kinds of treatment failed, including:
    • DLBCL
    • Primary mediastinal large B-cell lymphoma
    • High grade B-cell lymphoma
    • DLBCL arising from follicular lymphoma

 To refer a patient to our CAR T-cell therapy program, please call 1-844-482-7823.

Refer a Pediatric Patient

 Kymriah (tisagenlecleucel) CAR T-cell therapy is available for patients with: 

  • Primary refractory B-cell pediatric acute lymphoblastic leukemia (ALL)
  • Relapsed or refractory B-cell acute lymphoblastic leukemia (ALL)
  • Relapsed B-cell acute lymphoblastic leukemia (ALL)

To refer a patient to our CAR T-cell therapy program, please call 1-844-482-7823.

UChicago Medicine Cancer Care Locations